Crossmark

Berberine-loaded albumin nanoparticles reverse aflatoxin B1-induced liver hyperplasia

Published Online: 2023-08-10

Authors

Khedr, Sarah M.

Ghareeb, Doaa A. http://orcid.org/0000-0003-3327-4377
Fathy, Shadia A.

Hamdy, Germine M.
Funding

Funding for this research was provided by:

Alexandria University
License Information

Text and Data Mining valid from 2023-08-10

Version of Record valid from 2023-08-10
More Information

Article History

Received: 3 December 2022

Accepted: 1 August 2023

First Online: 10 August 2023

Declarations

:

: We declare that all experiments were approved by the Faculty of Science, Alexandria University Pharmaceutical and Fermentation Industries Development Center, Scientific Research, and Technological Application City.In addition, all experimental procedures for animals were performed according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals approved by the Institutional Animal Care and Use Committees (IACUCs) of Pharmaceutical and Fermentation Industries Development Center, Scientific Research, and Technological Application City with approval number 21-1S-2220.Finally, we declare that all experiments were performed according to ARRIVE guidelines.

: Not applicable.

: The authors declare no competing interests.

Document is current